(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction...
Stats | |
---|---|
今日成交量 | 373.00 |
平均成交量 | 5 814.00 |
市值 | 70.11M |
EPS | $0 ( 2024-02-09 ) |
下一个收益日期 | ( $-0.110 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -6.59 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-29 | Cundy Kenneth C | Buy | 72 613 | Stock Option (right to buy) |
2024-02-29 | Cundy Kenneth C | Buy | 72 613 | Stock Option (right to buy) |
2023-12-18 | English Aron R. | Buy | 300 000 | Common Stock |
2023-11-13 | English Aron R. | Buy | 300 000 | Common Stock |
2023-12-18 | English Aron R. | Sell | 300 000 | Common Stock |
INSIDER POWER |
---|
65.49 |
Last 33 transactions |
Buy: 5 891 747 | Sell: 793 740 |
Anebulo Pharmaceuticals, 财务报表
Annual | 2023 |
营收: | $0 |
毛利润: | $0 (0.00 %) |
EPS: | $-0.470 |
FY | 2023 |
营收: | $0 |
毛利润: | $0 (0.00 %) |
EPS: | $-0.470 |
FY | 2022 |
营收: | $0 |
毛利润: | $0 (0.00 %) |
EPS: | $-0.290 |
FY | 2021 |
营收: | $0.00 |
毛利润: | $0.00 (0.00 %) |
EPS: | $-2.83 |
Financial Reports:
No articles found.
Anebulo Pharmaceuticals,
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The company was incorporated in 2020 and is based in Lakeway, Texas.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。